Novo Nordisk Offers $9 Billion Unsolicited Bid for Obesity Drug Maker Metsera
Novo Nordisk has launched a surprise $9bn (£6.9bn) offer for the US obesity-focused biotech firm Metsera that could gazump an existing bid from Pfizer as the pharmaceutical giants fight for dominance in the weight-loss market.The…
